Literature DB >> 3042206

Standardization of lipid, lipoprotein, and apolipoprotein measurements.

G R Cooper1, G L Myers, S J Smith, E J Sampson.   

Abstract

Accurate laboratory measurement of serum cholesterol has become a national public health priority. National proficiency testing surveys indicate that laboratory inaccuracy in cholesterol testing is more of a problem than precision. Like precision, accuracy is a function of multiple pre-analytical and analytical sources of variation. Controlling pre-analytical sources of variation helps minimize such sources of variation as intraperson biological, behavioral, and clinical differences, and variations caused by sample collection, handling, and shipping. Standardization of analytical sources of variation helps to achieve and maintain desirable analytical performance, accurate reporting, and correct interpretation of a reported cholesterol result. The intraperson total variation in lipoproteins and their constituents is of primary interest when one is interpreting a single result or a series of results from a single person. The mean of multiple specimens from the same person is required if one is to obtain an accurate value for intraperson total cholesterol and minimize pre-analytical sources of variation. Standardizing analytical sources of variation in some instrument systems requires standardizing results by using "fresh" patients' specimens.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3042206

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  9 in total

1.  Effect of biological and analytical variation in cholesterol measurement on the cost-effectiveness of cholesterol-lowering therapy.

Authors:  L L Martens
Journal:  Pharmacoeconomics       Date:  1992-11       Impact factor: 4.981

2.  Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease.

Authors:  Zhao-Xia Yang; Wei Shen; Hang Sun
Journal:  Hepatol Int       Date:  2010-08-12       Impact factor: 6.047

3.  Total cholesterol performance of Abell-Levy-Brodie-Kendall reference measurement procedure: Certification of Japanese in-vitro diagnostic assay manufacturers through CDC's Cholesterol Reference Method Laboratory Network.

Authors:  Masakazu Nakamura; Hiroyasu Iso; Akihiko Kitamura; Hironori Imano; Masahiko Kiyama; Shinji Yokoyama; Yuzo Kayamori; Isao Koyama; Kunihiro Nishimura; Michikazu Nakai; Mahnaz Dasti; Hubert W Vesper; Tamio Teramoto; Yoshihiro Miyamoto
Journal:  Clin Chim Acta       Date:  2015-03-26       Impact factor: 3.786

4.  Positive effect of hydroxychloroquine on lipid profiles of patients with rheumatoid arthritis: A Veterans Affair cohort.

Authors:  Myriam Guevara; Bernard Ng
Journal:  Eur J Rheumatol       Date:  2020-11-05

5.  The effects of errors in lipid measurement and assessment.

Authors:  Gerald R Cooper; Gary L Myers; Mary M Kimberly; And Parvin P Waymack
Journal:  Curr Cardiol Rep       Date:  2002-11       Impact factor: 2.931

6.  A double-blind comparison of the effects of carvedilol and captopril on serum lipid concentrations in patients with mild to moderate essential hypertension and dyslipidaemia.

Authors:  U Hauf-Zachariou; L Widmann; B Zülsdorf; M Hennig; P D Lang
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

7.  Effects of pre-analytical processes on blood samples used in metabolomics studies.

Authors:  Peiyuan Yin; Rainer Lehmann; Guowang Xu
Journal:  Anal Bioanal Chem       Date:  2015-03-04       Impact factor: 4.142

8.  Reproducibility of the serum lipid response to coffee oil in healthy volunteers.

Authors:  Mark V Boekschoten; Mariëlle F Engberink; Martijn B Katan; Evert G Schouten
Journal:  Nutr J       Date:  2003-10-04       Impact factor: 3.271

9.  Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia and LDL-C of 160 mg/dl or Higher.

Authors:  Henry N Ginsberg; Daniel J Rader; Frederick J Raal; John R Guyton; Marie T Baccara-Dinet; Christelle Lorenzato; Robert Pordy; Erik Stroes
Journal:  Cardiovasc Drugs Ther       Date:  2016-10       Impact factor: 3.727

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.